Month: June 2019

Fibonacci Retracement
Fundamental Analysis
Tech Industry
Tech Stocks
Technical Analysis
Value Investing
Value Stocks

Just how underrated is CTSH?

After watching a wide swath of sectors in the market correct during the month of May as trade tensions seemed to doom the market to the inevitability of long-term tariffs, it seemed like the market could be set to drop back close to the near-bear-market levels we saw at the end of 2018. Instead, the […]

Read More
Breaking News
China
Economy
ETF
Federal Reserve
Risk
Trade War

Morgan Stanley Says Now Is The Time To Buy This Unloved Asset Class

The bank is now bullish on this asset class. The question is, should you get in on this trade?

Read More
China
Stock Picks
Tech Stocks
Trade War

Why This Beaten-Down Stock Could Be On The Verge Of A Breakout Higher

Sentiment has bruised this stock, but one technical analyst says it could be about to surge higher.

Read More
Daily Perspective
Gold
Oil

Here’s the Biggest Misconception About the Relationship Between Gold and Oil

Any investor who tracks commodities knows that gold and oil have been among the year’s top performers. The price of gold per ounce has climbed over 10% from $1,281.30 on Dec. 31 toward a six-year high of $1,412 as of June 27, while the price of West Texas Intermediate (WTI) — the U.S. benchmark for […]

Read More
Federal Reserve
S&P 500
Stock Picks
Volatility

7 Stocks Goldman Sachs Says Will Beat The Market If The Fed Cuts Rates In July

Stocks with this feature have outperformed the rest of the market after the Fed cuts rates, and these 7 stocks fit the bill.

Read More
Breaking News
Fibonacci Retracement
Fundamental Analysis
Risk
Semiconductor
Tariffs
Tech Industry
Tech Stocks
Technical Analysis
Trade War
Value Investing
Value Stocks
Value Traps

Chip stocks just got an unexpected boost – but that doesn’t make XLNX a bargain yet

Tuesday after the market closed, Micron Technology (MU) released its latest quarterly earnings report. MU is one of the most important players in the semiconductor industry, and since semiconductors are quite literally on the bleeding edge of U.S. – China trade, it only seems natural to pay attention to the stock. Their earnings report is […]

Read More
Daily Perspective
S&P 500
Stock Buyback

These S&P 500 Companies Spent the Most on Buybacks in Q1

Stock buybacks have been a divisive practice ever since the Securities and Exchange Commission (SEC) started allowing them in 1982. When a company implements a buyback program, it essentially repurchases shares of the company from public shareholders, thus drastically reducing the number of outstanding shares on the open market. Not only does this give the […]

Read More
Banking Sector
Fibonacci Retracement
Financial Sector
Fundamental Analysis
Technical Analysis
US Economy
Value Investing
Value Stocks

Does an accommodative Fed make bank stocks like KEY more attractive?

It seems like one of the only elements that really seems to get investor’s attention, aside from the latest rumor about trade and tariffs, is anything to do with interest rates. I guess that isn’t too surprising  – central banking policy about interest rates has always wielded considerable influence on the financial markets. I think […]

Read More
Daily Perspective
IPO
Technology

The 5 Best-Performing IPOs of 2019 So Far

The first half of the year is almost in the bag, and while the major market indexes continue their overall trend higher, the IPO market has been 2019’s biggest unsung winner. While strong economic data and a broader market rally are cited as the IPO market’s biggest drivers, much of the bullish sentiment can be […]

Read More
Biotech
Daily Perspective
Pharmaceuticals

Here’s How Massive AbbVie Will Become After Buying Allergan

One of the year’s biggest merger announcements sent shockwaves through the U.S. pharmaceutical sector on Tuesday when Humira drugmaker AbbVie Inc. (ABBV) struck a deal to acquire Botox producer Allergan Plc. (AGN). Investors reacted strongly to the news, making ABBV and AGN the market’s single biggest loser and winner, respectively.  After the deal closes, AbbVie […]

Read More
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Pharmaceuticals
Risk
Technical Analysis
Valuations
Value Investing
Value Stocks
Volatility

Big value proposition, plus a blockbuster pending merger: is BMY a smart trade right now?

If you’ve followed my highlights in this space, you’ve seen me write on a number of occasions about how my value-focused investing approach tends to make me think in defensive terms under current market conditions. As the major indices are driving to new all-time highs, a lot of growth-oriented folks think that sounds pretty silly; […]

Read More
Daily Perspective
IPO

The 5 Biggest IPOs Coming Up This Week

The IPO market is set to wrap up a particularly strong month this week, which should see nine deals raise a combined $2.1 billion in proceeds by Friday, June 28. Last week saw six IPOs and a special purpose acquisition company (SPAC) hit the market, but most headlines concerned the unique direct listing of popular […]

Read More
X